Mutations and aberrant DNA methylation of the PROX1 gene in hematologic malignancies

Hirokazu Nagai1, Yinghua Li, Sonoko Hatano

  • 11st Department of Internal Medicine, Nagoya University School of Medicine, Showa-ku, Nagoya, Japan. nagaih@nnh.hosp.go.jp

Insights

The PROX1 gene, linked to development, shows mutations and silencing in blood cancers due to DNA hypermethylation. This suggests PROX1 acts as a tumor suppressor, offering potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • The homeobox gene PROX1 is evolutionarily conserved, with roles in the developing central nervous system and lens.
  • Dysregulation of homeobox genes is implicated in various cancers.

Purpose of the Study:

  • To investigate the role of the PROX1 gene in hematologic malignancies.
  • To determine the mechanisms of PROX1 gene silencing in cancer cells.

Main Methods:

  • Analysis of PROX1 gene mutations and mRNA expression in hematologic cell lines using sequencing and RT-PCR.
  • Treatment of cell lines with a demethylating agent (5-aza-2'-deoxycytidine) to assess gene expression restoration.
  • Bisulfite sequencing to analyze DNA methylation status at the PROX1 gene locus.
  • Examination of PROX1 methylation in primary lymphoma samples.

Main Results:

  • Missense and nonsense mutations in PROX1 were identified in 4 out of 29 hematologic cell lines.
  • Reduced PROX1 mRNA expression was observed in approximately 50% of analyzed cell lines.
  • PROX1 gene expression was restored upon treatment with 5-aza-2'-deoxycytidine, indicating epigenetic regulation.
  • DNA hypermethylation, specifically at intron 1 of PROX1, was identified as the mechanism for gene silencing.
  • Tumor-specific hypermethylation of PROX1 was found in 56.3% of primary lymphoma samples.

Conclusions:

  • The PROX1 gene exhibits characteristics of a tumor suppressor gene in hematologic malignancies.
  • DNA hypermethylation-induced silencing of PROX1 is a significant event in lymphomagenesis.
  • PROX1 alterations represent a potential biomarker and therapeutic target in blood cancers.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...